Announced Wed, 20 May · 13:32 IST

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹35.50
prior close
₹34.93
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+2.8-1.6+0.5+2.8+2.3-5.6-3.5-7.9-6.1
Up moveDown movePending
AI summary

Kimia Biosciences Limited has informed BSE that a Board meeting is scheduled for 29th May, 2026 to consider and approve the Audited Financial Results (Standalone) for the quarter and financial year ended 31st March, 2026 along with the Audit Report. The trading window, which was closed from 1st April, 2026, will continue to remain closed till 48 hours after the declaration of the financial results. This is a standard procedural filing under SEBI regulations and does not contain any financial figures or audit opinions.

Likely market impact

This is a routine board meeting notice and does not provide any indication of financial performance. Actual results and any audit opinions will be disclosed in a separate filing after the board meeting on 29th May, 2026.